Literature DB >> 30417041

Data on excessive risk of cancer from gamma radiation in residents of Bojnurd city.

Mohsen Khosroabadi1, Seyed Abolghasem Haeri2, Homa Rezaei Moghaddam3, Mohammad Mirdoraghi4.   

Abstract

The aim of the data was to measure the absorbed dose of gamma radiation in order to estimate the excessive risk of cancer-induced gamma radiation during the lifetime of Bojnurd residents. In this descriptive cross-sectional study, gamma radiations in 30 places was measured in Bojnurd City during four seasons in 2015. A dosimeter was stacked on a tripod at 1 m from the ground for 50 minutes, and then, the absorbed dose of gamma radiation was recorded in the checklist. Ultimately, the effective dose and the excessive lifetime risk of cancer were determined. The mean ± SE of absorbed dose of gamma radiation in spring, summer, autumn, winter was 134.25 ± 1.45; 139.89 ± 1.64; 134.40 ± 1.25; 143.80 ± 1.73 nGy, respectively. The average annual effective dose by residents in open space was estimated at an average of 0.167 mSv. Also, the excessive risk of cancer-induced gamma radiation was equal to 0.67 × 10-3. The annual effective dose and the excessive risk of cancer-induced gamma radiation during the lifetime of Bojnurd residents are higher than the global average.

Entities:  

Keywords:  Bojnurd; Cancer; Effective dose; Gamma

Year:  2018        PMID: 30417041      PMCID: PMC6216078          DOI: 10.1016/j.dib.2018.10.052

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications table Value of the data The data can be used to show that the amount of the absorbed dose of gamma radiation in residents of Bojnuurd city in open space is more than the global average. The data demonstrated that the effective dose from the background radiation was 0.167 Millisievert per year, which is more than two times the universal standard. The calculated ELCR is higher than the global average of the risk of cancer-inducing gamma radiation during the lifetime of the residents of Bojnurd.

Data

The average of all samples in the open environment is 137.10 nGy/h (Nanogray per hour). The maximum of gamma radiation measurement was 255 nGy/h and the lowest value measured was 53 nGy/h [Table 1]. The ANOVA and Scheffe post hoc test were shown that there is a significant relationship between measured gamma radiation in winter with the measured values in autumn and spring (P < 0.05). There was no any significant relation between other seasons (P > 0.05) [Table 2].
Table 1

The mean, Std. Error, maximum, minimum of measured gamma radiation (nGy), the effective dose (mSv) and ELCR per year are shown with 95% Confidence Interval for Mean.

SeasonNMeanStd. Error95% Confidence interval for mean
MinimumMaximumThe effective dose (mSv)ELCR × 10-3
Lower boundUpper bound
Spring360134.251.45619131.3835137.111065.00255.000.04110.164
Summer360139.891.64803136.6451143.127153.00233.000.04280.171
Autumn360134.401.25166131.9357136.858777.00206.000.04120.164
Winter148143.801.73549140.3743147.233889.00215.000.04400.175
Total (Annual)1228137.10.77632135.5730138.619153.00255.000.1680.67
Table 2

Comparison between measured gamma radiations in four seasons by Scheffe post hoc test.

(I) Season(J) SeasonMean difference (I-J)Std. ErrorSig.95% Confidence Interval
Lower boundUpper bound
SpringSummer−5.63889*2.01333.050−11.2750−.0028
Autumn−.150002.013331.000−5.78615.4861
Winter−9.55683*2.63755.004−16.9403−2.1733
SummerSpring5.63889*2.01333.050.002811.2750
Autumn5.488892.01333.060−.147211.1250
Winter−3.917942.63755.531−11.30153.4656
AutumnSpring.150002.013331.000−5.48615.7861
Summer−5.488892.01333.060−11.1250.1472
Winter−9.40683*2.63755.005−16.7903−2.0233
WinterSpring9.55683*2.63755.0042.173316.9403
Summer3.917942.63755.531−3.465611.3015
Autumn9.40683*2.63755.0052.023316.7903

The mean difference is significant at the 0.05 level.

The mean, Std. Error, maximum, minimum of measured gamma radiation (nGy), the effective dose (mSv) and ELCR per year are shown with 95% Confidence Interval for Mean. Comparison between measured gamma radiations in four seasons by Scheffe post hoc test. The mean difference is significant at the 0.05 level. According to the Eq. (3), the annual effective dose for residents of Bojnurd city was equal to 0.168 mSv. Based on the following equation, the risk of inducing cancer by receiving gamma radiation can be calculated [4], [5]. ELCR = Excess Lifetime Cancer Risk E = Annual effective dose in mSv DL = Average lifespan (year) RF = Fatal risk factor per Sievert for the public (0/057 Sv−1). ELCR = 0.168 ×70/1 × 0/057 = 0.67 × 10−3

Experimental design, materials and methods

The data were derived from a descriptive cross-sectional study, which was conducted in Bojnurd. To select the measuring sites, a comprehensive map of Bojnurd City was prepared according to the distribution of population [Fig. 1]. 30 places were considered. A dosimeter was installed at one meter from the ground along the main directions of northern, southern,eastern, western and sub-directions on a tripod in an open environment to examine the gamma background radiation. Selected locations for measurement were flat, no trees, buildings or walls in that area.
Fig. 1

The 30 places in Bojnurd, where the absorbed dose of gamma radiation was measured [3].

The 30 places in Bojnurd, where the absorbed dose of gamma radiation was measured [3]. The dosimeter was carried out by the Inspector Survey Meter, which can monitor gamma, beta, x-ray and alpha radiations. The operating range is 0.1 to 1000 µSv/hr. Data were recorded in the checklist and then analyzed by SPSS 16. In order to determine the significant differences between seasons, the data were analyzed by ANOVA and Scheffe post hoc test with statistical confidence interval of 95%. For the purpose of evaluating the effect of ionizing radiation on human biological systems, the International Commission on Radiological Protection (ICRP) is considered equivalent dose which defined based on absorbed dose. Using the following equation, the annual effective dose of gamma radiation of Bojnurd City, which is the sum of cosmic radiations and radiations emitted from radioactive substances in the earth׳s crust, was calculated [8], [9]. In this case, E is an effective dose, C is the conversion factor of absorbed dose to effective dose which is 0.7, T is the conversion factor of hour to year, Dout is the absorbed dose of gamma radiations in open space. 0.2 is also related to open space occupancy factor [4], [5], [6], [7]. Ultimately, based on the following equation, the risk of inducing cancer by receiving gamma radiation was calculated [10], [11]. ELCR = Excess Lifetime Cancer Risk E = Annual effective dose in mSv DL = Average lifespan (year) RF = Fatal risk factor per Sievert for the public (0/057 Sv−1).
Subject areaRadiation biology and radiation protection.
More specific subject areaDetermine the Excessive Risk of Cancer from Gamma Radiation.
Type of dataTables.
How data was acquiredTo calculate the excessive risk of cancer induced by gamma radiation, a dosimeter was stacked on a tripod at 1 m from the ground for 50 minutes, and then, the absorbed dose of gamma radiation was recorded in the checklist. Ultimately, the effective dose and the excessive lifetime risk of cancer were estimated based on standard equations [1], [2].
Data formatRaw, Analyzed.
Experimental factorsThe absorbed dose of gamma and the effective dose were analyzed according to the standards
Experimental featuresThe absorbed dose of gamma radiation, the effective dose and also the excessive lifetime risk of cancer were determined.
Data source locationBojnurd, Iran.
Data accessibilityThe data are available with this article
  2 in total

1.  Data on the estimating the risk of cancer due to some common radiographs in Tehran city.

Authors:  Mohammad Mirdoraghi; Amin Banaei; Jafar Fatahi Asl
Journal:  Data Brief       Date:  2018-09-06

2.  Data on assessment excess lifetime cancer risk and risk of lung cancer from inhalation of Radon 222 in radiotherapy centers in Tehran, Iran.

Authors:  Mohammad Mirdoraghi; Safdar Masoumi; Daniel Einor
Journal:  Data Brief       Date:  2018-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.